story of the week
Secukinumab Appears Effective and Safe for Children With Severe Chronic Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secukinumab Demonstrates High Efficacy and a Favourable Safety Profile in Paediatric Patients With Severe Chronic Plaque Psoriasis: 52-Week Results From a Phase 3 Double-Blind Randomized, Controlled Trial
J Eur Acad Dermatol Venereol 2020 Oct 17;[EPub Ahead of Print], C Bodemer, A Kaszuba, K Kingo, A Tsianakas, A Morita, E Rivas, P Papanastasiou, D Keefe, M Patekar, P Charef, L Zhang, S Cafoncelli, C PapavassilisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.